HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

davunetide

AL-108 is a nasal systemic formulation; AL-208 is an intravenous formulation; associated with glial proteins regulated by vasoactive intestinal peptide, are shown now to provide protective intervention in a model of fetal alcohol syndrome
Also Known As:
AL 108; AL 208; AL-108; AL-208; AL-408; AL108 cpd; AL208 cpd; D-NAP peptide; NAP peptide; NAPVSIPQ peptide
Networked: 37 relevant articles (9 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gozes, Illana: 17 articles (01/2021 - 10/2009)
2. Boxer, Adam L: 4 articles (05/2020 - 07/2014)
3. Gold, Michael: 4 articles (07/2014 - 01/2012)
4. Morimoto, Bruce H: 4 articles (07/2014 - 01/2012)
5. Ivashko-Pachima, Yanina: 3 articles (01/2021 - 01/2012)
6. Höglinger, Günter U: 3 articles (01/2017 - 07/2014)
7. Stewart, Alistair J: 3 articles (07/2014 - 01/2012)
8. Giladi, Eliezer: 3 articles (08/2013 - 07/2010)
9. Heuer, Hilary W: 2 articles (05/2020 - 07/2014)
10. Koestler, Mary: 2 articles (05/2020 - 07/2014)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Cognitive Dysfunction
3. Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
4. Alzheimer Disease (Alzheimer's Disease)
5. Tauopathies

Related Drugs and Biologics

1. Antioxidants
2. Peptides (Polypeptides)
3. Glutathione Disulfide (GSSG)
4. Kainic Acid (Kainate)
5. Free Radicals
6. tideglusib
7. Riluzole
8. Choline (Choline Chloride)
9. Proteins (Proteins, Gene)
10. davunetide

Related Therapies and Procedures

1. Activities of Daily Living (ADL)
2. Therapeutics
3. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4. Intranasal Administration